Management of anaphylaxis: a systematic review

S Dhami, S S Panesar, G Roberts, A Muraro, M Worm, M B Bilò, V Cardona, A E J Dubois, A DunnGalvin, P Eigenmann, M Fernandez-Rivas, S Halken, G Lack, B Niggemann, F Rueff, A F Santos, B Vlieg-Boerstra, Z Q Zolkipli, A Sheikh, EAACI Food Allergy and Anaphylaxis Guidelines GroupCarsten Bindslev-Jensen

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

To establish the effectiveness of interventions for the acute and long-term management of anaphylaxis, seven databases were searched for systematic reviews, randomized controlled trials, quasi-randomized controlled trials, controlled clinical trials, controlled before-after studies and interrupted time series and - only in relation to adrenaline - case series investigating the effectiveness of interventions in managing anaphylaxis. Fifty-five studies satisfied the inclusion criteria. We found no robust studies investigating the effectiveness of adrenaline (epinephrine), H1-antihistamines, systemic glucocorticosteroids or methylxanthines to manage anaphylaxis. There was evidence regarding the optimum route, site and dose of administration of adrenaline from trials studying people with a history of anaphylaxis. This suggested that administration of intramuscular adrenaline into the middle of vastus lateralis muscle is the optimum treatment. Furthermore, fatality register studies have suggested that a failure or delay in administration of adrenaline may increase the risk of death. The main long-term management interventions studied were anaphylaxis management plans and allergen-specific immunotherapy. Management plans may reduce the risk of further reactions, but these studies were at high risk of bias. Venom immunotherapy may reduce the incidence of systemic reactions in those with a history of venom-triggered anaphylaxis.

OriginalsprogEngelsk
TidsskriftAllergy
Vol/bind69
Udgave nummer2
Sider (fra-til)168-75
ISSN0105-4538
DOI
StatusUdgivet - feb. 2014

Fingeraftryk

Randomized Controlled Trials
Histamine Antagonists
Quadriceps Muscle
Controlled Clinical Trials
Databases
Muscles
Incidence
Interrupted Time Series Analysis
methylxanthine
Controlled Before-After Studies

Citer dette

Dhami, S., Panesar, S. S., Roberts, G., Muraro, A., Worm, M., Bilò, M. B., ... Bindslev-Jensen, C. (2014). Management of anaphylaxis: a systematic review. Allergy, 69(2), 168-75. https://doi.org/10.1111/all.12318
Dhami, S ; Panesar, S S ; Roberts, G ; Muraro, A ; Worm, M ; Bilò, M B ; Cardona, V ; Dubois, A E J ; DunnGalvin, A ; Eigenmann, P ; Fernandez-Rivas, M ; Halken, S ; Lack, G ; Niggemann, B ; Rueff, F ; Santos, A F ; Vlieg-Boerstra, B ; Zolkipli, Z Q ; Sheikh, A ; EAACI Food Allergy and Anaphylaxis Guidelines Group ; Bindslev-Jensen, Carsten. / Management of anaphylaxis : a systematic review. I: Allergy. 2014 ; Bind 69, Nr. 2. s. 168-75.
@article{01f3f0cebb9a4ad4940a726ca972feb3,
title = "Management of anaphylaxis: a systematic review",
abstract = "To establish the effectiveness of interventions for the acute and long-term management of anaphylaxis, seven databases were searched for systematic reviews, randomized controlled trials, quasi-randomized controlled trials, controlled clinical trials, controlled before-after studies and interrupted time series and - only in relation to adrenaline - case series investigating the effectiveness of interventions in managing anaphylaxis. Fifty-five studies satisfied the inclusion criteria. We found no robust studies investigating the effectiveness of adrenaline (epinephrine), H1-antihistamines, systemic glucocorticosteroids or methylxanthines to manage anaphylaxis. There was evidence regarding the optimum route, site and dose of administration of adrenaline from trials studying people with a history of anaphylaxis. This suggested that administration of intramuscular adrenaline into the middle of vastus lateralis muscle is the optimum treatment. Furthermore, fatality register studies have suggested that a failure or delay in administration of adrenaline may increase the risk of death. The main long-term management interventions studied were anaphylaxis management plans and allergen-specific immunotherapy. Management plans may reduce the risk of further reactions, but these studies were at high risk of bias. Venom immunotherapy may reduce the incidence of systemic reactions in those with a history of venom-triggered anaphylaxis.",
author = "S Dhami and Panesar, {S S} and G Roberts and A Muraro and M Worm and Bil{\`o}, {M B} and V Cardona and Dubois, {A E J} and A DunnGalvin and P Eigenmann and M Fernandez-Rivas and S Halken and G Lack and B Niggemann and F Rueff and Santos, {A F} and B Vlieg-Boerstra and Zolkipli, {Z Q} and A Sheikh and {EAACI Food Allergy and Anaphylaxis Guidelines Group} and Carsten Bindslev-Jensen",
note = "{\circledC} 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2014",
month = "2",
doi = "10.1111/all.12318",
language = "English",
volume = "69",
pages = "168--75",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley Online",
number = "2",

}

Dhami, S, Panesar, SS, Roberts, G, Muraro, A, Worm, M, Bilò, MB, Cardona, V, Dubois, AEJ, DunnGalvin, A, Eigenmann, P, Fernandez-Rivas, M, Halken, S, Lack, G, Niggemann, B, Rueff, F, Santos, AF, Vlieg-Boerstra, B, Zolkipli, ZQ, Sheikh, A, EAACI Food Allergy and Anaphylaxis Guidelines Group & Bindslev-Jensen, C 2014, 'Management of anaphylaxis: a systematic review', Allergy, bind 69, nr. 2, s. 168-75. https://doi.org/10.1111/all.12318

Management of anaphylaxis : a systematic review. / Dhami, S; Panesar, S S; Roberts, G; Muraro, A; Worm, M; Bilò, M B; Cardona, V; Dubois, A E J; DunnGalvin, A; Eigenmann, P; Fernandez-Rivas, M; Halken, S; Lack, G; Niggemann, B; Rueff, F; Santos, A F; Vlieg-Boerstra, B; Zolkipli, Z Q; Sheikh, A; EAACI Food Allergy and Anaphylaxis Guidelines Group ; Bindslev-Jensen, Carsten.

I: Allergy, Bind 69, Nr. 2, 02.2014, s. 168-75.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - Management of anaphylaxis

T2 - a systematic review

AU - Dhami, S

AU - Panesar, S S

AU - Roberts, G

AU - Muraro, A

AU - Worm, M

AU - Bilò, M B

AU - Cardona, V

AU - Dubois, A E J

AU - DunnGalvin, A

AU - Eigenmann, P

AU - Fernandez-Rivas, M

AU - Halken, S

AU - Lack, G

AU - Niggemann, B

AU - Rueff, F

AU - Santos, A F

AU - Vlieg-Boerstra, B

AU - Zolkipli, Z Q

AU - Sheikh, A

AU - EAACI Food Allergy and Anaphylaxis Guidelines Group

AU - Bindslev-Jensen, Carsten

N1 - © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PY - 2014/2

Y1 - 2014/2

N2 - To establish the effectiveness of interventions for the acute and long-term management of anaphylaxis, seven databases were searched for systematic reviews, randomized controlled trials, quasi-randomized controlled trials, controlled clinical trials, controlled before-after studies and interrupted time series and - only in relation to adrenaline - case series investigating the effectiveness of interventions in managing anaphylaxis. Fifty-five studies satisfied the inclusion criteria. We found no robust studies investigating the effectiveness of adrenaline (epinephrine), H1-antihistamines, systemic glucocorticosteroids or methylxanthines to manage anaphylaxis. There was evidence regarding the optimum route, site and dose of administration of adrenaline from trials studying people with a history of anaphylaxis. This suggested that administration of intramuscular adrenaline into the middle of vastus lateralis muscle is the optimum treatment. Furthermore, fatality register studies have suggested that a failure or delay in administration of adrenaline may increase the risk of death. The main long-term management interventions studied were anaphylaxis management plans and allergen-specific immunotherapy. Management plans may reduce the risk of further reactions, but these studies were at high risk of bias. Venom immunotherapy may reduce the incidence of systemic reactions in those with a history of venom-triggered anaphylaxis.

AB - To establish the effectiveness of interventions for the acute and long-term management of anaphylaxis, seven databases were searched for systematic reviews, randomized controlled trials, quasi-randomized controlled trials, controlled clinical trials, controlled before-after studies and interrupted time series and - only in relation to adrenaline - case series investigating the effectiveness of interventions in managing anaphylaxis. Fifty-five studies satisfied the inclusion criteria. We found no robust studies investigating the effectiveness of adrenaline (epinephrine), H1-antihistamines, systemic glucocorticosteroids or methylxanthines to manage anaphylaxis. There was evidence regarding the optimum route, site and dose of administration of adrenaline from trials studying people with a history of anaphylaxis. This suggested that administration of intramuscular adrenaline into the middle of vastus lateralis muscle is the optimum treatment. Furthermore, fatality register studies have suggested that a failure or delay in administration of adrenaline may increase the risk of death. The main long-term management interventions studied were anaphylaxis management plans and allergen-specific immunotherapy. Management plans may reduce the risk of further reactions, but these studies were at high risk of bias. Venom immunotherapy may reduce the incidence of systemic reactions in those with a history of venom-triggered anaphylaxis.

U2 - 10.1111/all.12318

DO - 10.1111/all.12318

M3 - Review

C2 - 24251536

VL - 69

SP - 168

EP - 175

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 2

ER -

Dhami S, Panesar SS, Roberts G, Muraro A, Worm M, Bilò MB et al. Management of anaphylaxis: a systematic review. Allergy. 2014 feb;69(2):168-75. https://doi.org/10.1111/all.12318